home > news > detailed info

Business Continuity Plan - Message from Protagen Protein Services (PPS)

Protagen Protein Services

Following the recent COVID-19 outbreak, we at Protagen Protein Services (PPS) are preparing for all eventualities. Please be assured that PPS will continue to operate as normal providing you with all of the professional support and service you have to come to expect from us.

Given the gravity of the situation, and to protect our staff, clients, and communities from the spread of the virus, we have taken various measures within a scope of a Business Continuity Plan:

• We have taken proactive actions, i.e. home office and travel reduction where possible, to isolate and protect our office and lab operation and have set what we see as best practices and policies.
• We have a robust and site-redundant lab operating systems in service for many years to assure continuity in our analytical services, data analysis, security and communications with our customers. Additionally, we installed multiple redundancy by a two group lab operation for each our two labs in Germany and independent US operations.
• Particularly due to our size, location and secure lab profile, we are able to closely control people coming in or out of our company, and we have proactively implemented processes in separating and protecting our analytic operations, while shifting to teleconference and virtual meetings with any of our customers and partners.

Our staff is readily available via all of the normal channels when needed. Our Analytical Team will continue to offer first-class service and support. In case of urgent resources needed, please contact us.

We are determined to defy the pandemic and do the best we can in these times. Stay safe and stay in touch.

Martin Blüggel

phone +49 231 9742 61 00
email Protagen Protein Services (GmbH), Inselwiesenstraße 10, D-74076 Heilbronn
Print this page
Send to a friend
News and Press Releases

SCHOTT Pharmaversity – Sharing expertise. Shaping tomorrow

Global pharma specialist in primary packaging SCHOTT launches a new service for the entire pharmaceutical industry. SCHOTT founded the Pharmaversity, an inspirational network hub for experts in the industry, provided by experts in glass and polymer. This is in line with SCHOTT’s mind-set to strongly focus on collaborative aspects as a key business driver and to share knowledge among the key players in the industry to move it forward together.
More info >>

White Papers

Considerations for Choosing the Right Wearable Drug Delivery System

West Pharmaceutical Services, Inc.

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement